Delivery Order SPE2DB20D3103-SPE2DB21FQ3V7
Award Date
9/21/21
Potential Completion Date
9/22/21
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of emtricitabine-tenofovir 200-300mg pharmaceutical products, valued at $1,979.52. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on June 21, 2023. The contract has a firm fixed-price delivery order type with a completion date of June 22, 2023. The award is not associated with a set-aside program and is part of AmerisourceBergen's larger Indefinite Delivery Contract...
The federal contract award is for the delivery of Emtricitabine-Tenofovir 200-300mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,633.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024, with a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,262.63 firm-fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 mg prescription medications. The contract has a completion date of February 2, 2022 and was awarded on February 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,319.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emtricitabine-Tenofovir 200-300 mg pharmaceutical products, with a completion date of May 10, 2022. This is a firm-fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a subsidiary of the parent company,...
This federal contract award is for the delivery of 4,560,287,376 units of the antiretroviral medication emtricitabine-tenofovir 200-300mg. The $1,457.61 firm fixed-price contract was awarded on March 16, 2023 by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of March 17, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of emtricitabine-tenofovir 200-300 mg medication to the Defense Logistics Agency (DLA). The $2,603.26 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 11, 2024 with a completion date of July 12, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products such as emtricitabine-tenofovir 200-300 mg tablets. The $2,801.00 firm-fixed-price contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award is a delivery order between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $1,073.17, is for the supply of emtricitabine-tenofovir (200-300 mg) medications. The award is not designated with a set-aside requirement, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,002.56 firm fixed-price delivery order is for the supply of Emtricitabine-Tenofovir 200-300mg prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the...